RxDoctor Payments Data

Lucille Sullivan

Physician Assistant · Keyport, NJNPI 1346834033

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.4% of the total across 807 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 59 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,759in general payments, 2019–2025

Across 807 payments — averaging $17.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • AbbVie$2K
  • Lilly USA, LLC$1K
  • Novo Nordisk$1K
  • Boehringer Ingelheim$588
  • Bayer$433
  • plus $7K from 53 others

What the payments were for

  • Consulting fees$3503%
  • Food & beverage$13,26196%
  • Education$1481%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)119$1,858
AbbVie97$1,576
Lilly USA, LLC109$1,482
Novo Nordisk87$1,319
Boehringer Ingelheim32$588
Bayer26$433
Xeris Pharmaceuticals, Inc.23$372
Antares Pharma, Inc.22$371
Sanofi-aventis U.S. LLC17$349
Corcept Therapeutics16$319
IBSA Pharma Inc.18$307
Radius Health, Inc.11$295
Pfizer32$293
Mallinckrodt Hospital Products Inc.14$283
Mannkind Corporation11$279
Esperion Therapeutics, Inc.13$267
Ascensia Diabetes Care US Inc.8$260
Madrigal Pharmaceuticals10$224
AstraZeneca(2 entities)14$208
Insulet Corporation7$180
Recordati_rare_diseases_inc.9$175
Cequr Corporation2$155
Medtronic5$148
Sequel Med Tech, LLC3$146
Ionis Pharmaceuticals, Inc.8$138
Ascendis Pharma Endocrinology Inc6$134
Amneal Pharmaceuticals LLC10$130
ANI Pharmaceuticals, Inc.9$128
Janssen Scientific Affairs, LLC1$125
Kyowa Kirin, Inc.4$117
Dexcom, Inc.5$110
Aurinia Pharma U.S., Inc.8$107
Novartis5$96
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$72
Vivus LLC4$68
Johnson & Johnson2$63
Cumberland Pharmaceuticals, Inc.2$56
Currax Pharmaceuticals LLC3$44
UCB, Inc.3$43
Hikma Pharmaceuticals USA3$43
Amarin Pharma, Inc.2$36
Neurocrine Biosciences, Inc.1$34
Lexicon Pharmaceuticals, Inc.1$33
Azurity Pharmaceuticals, Inc.2$32
Takeda Pharmaceuticals U.S.A., Inc.2$28
Tandem Diabetes Care, Inc.2$27
GSK2$24
Rhythm Pharmaceuticals, Inc.1$23
Acella Pharmaceuticals, LLC1$19
Lifescan, Inc.1$17
EUSA Pharma (US) LLC1$16
Ultragenyx Pharmaceutical Inc.1$16
Pacira Therapeutics, Inc.1$15
Kiniksa Pharmaceuticals, Ltd.1$15
Amphastar Pharmaceuticals, Inc.1$14
Sobi, Inc1$14
E.r. Squibb & Sons, L.L.C.1$13
Virtus Pharmaceuticals LLC1$13
Merck1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,759 in reported general payments places this provider in the 95th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide170$192,770
JardianceEmpagliflozin127$119,741
MounjaroTirzepatide58$74,692
Tresiba Flextouch U-100Insulin Degludec45$36,414
RybelsusSemaglutide18$34,146
TrulicityDulaglutide18$32,626
Tresiba Flextouch U-200Insulin Degludec22$30,904
JanuviaSitagliptin Phosphate34$26,784
Synjardy XrEmpagliflozin/Metformin Hcl13$20,798
FarxigaDapagliflozin Propanediol18$18,983
Lyumjev Kwikpen U-100Insulin Lispro-Aabc31$17,151
Fiasp FlextouchInsulin Aspart (Niacinamide)11$14,911
Humalog Kwikpen U-100Insulin Lispro29$10,993
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$10,699
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/711$6,879

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Novolog$1,319$229,878202 claims
Boehringer IngelheimJardiance, Synjardy Xr$588$140,540140 claims
Lilly USA, LLCMounjaro, Trulicity$1,482$107,31776 claims
MerckJanuvia$12$26,78434 claims
AstraZenecaFarxiga$208$18,98318 claims
AbbVieSynthroid$1,576$6,72879 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$130$3,160203 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,726 physician assistant providers in New Jersey.

Other physician assistant in Keyport

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →